James Green
Translating the complexity of a world in motion into the intelligence you need.
About This Column
James Green is a writer and strategist dedicated to finding the "signal in the noise" of modern progress. Building on a career spent deconstructing the high-stakes world of biotech and medical innovation, James now applies his forensic curiosity to the broader forces of change. He specializes in translating complex technological, market, and social shifts into clear, actionable insights. Whether he is analyzing a disruptive new industry, a shift in global investment, or the future of infrastructure, James provides the critical context needed to understand how today’s breakthroughs will reshape our world tomorrow.
Displaying items 81-100 of 525 in total
Super Age Games: The New Olympics of Longevity Redefines Fitness
Indiana Reverses Course on 340B, Securing Health Center Lifeline
Pictet Challenges EM Investing With New China-Free Equity ETF
Digital Immortality: AI and Drones Race to Save Our Fading Past
Mangrove Health Launches to Reshape Florida's Primary Care Landscape
M31 Unlocks 2nm Era with TSMC, Tapes Out Key IP for AI & Mobile
Kimpton Ashbel Opens on Park Avenue, Blending History and Home
Digney Holding Forges Vertically Integrated Hospitality Powerhouse
Octen Debuts Ultra-Fast Search API to Power the AI Agent Era
Tailored Brands Plots Public Return After Post-Bankruptcy Revival
FDA Clears SINEFIX Implant for Wide Use in Soft Tissue Repair
ProShares Debuts First 2x Platinum & Palladium Leveraged ETFs
Kleinfelder Taps Veteran Goershel for Federal Market Offensive
Arçelik Exits Hitachi JV as Appliance Unit Moves to Nojima Control
RBB Bancorp Beats Q1 Forecasts on Margin Growth, Strong Deposits
Biorem's Record 2025: Clean-Tech Firm Soars on Innovation, Strategy
Globe Life Q1 Earnings: A Bellwether for the Middle-Income Market
Founder Returns to Helm of Controversial Gene-Screening Firm
Arvos Acquires Père Olive in a Mediterranean Food Power Play
